Lifepro Asset Management / ALNY
Lifepro Asset Management’s Alnylam Pharmaceuticals Inc Position
Does Lifepro Asset Management own Alnylam Pharmaceuticals Inc (ALNY)? Not currently — the last reported position was 21.9K shares worth $4M in Q3 2022; the fund’s latest 13F (Q3 2024) no longer reports it.
Position Value
$4M
Q3 2022
Shares
21.9K
% of Portfolio
+2.52%
Quarters Held
1
position exited
Position History ALNY
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q3 2022 | 21.9K | $4M | +2.52% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Lifepro Asset Management’s full portfolio or all institutional holders of ALNY.